SENSEX NIFTY

Us Food And Drug Administration

Mar 04, 2015 at 15:10 | Source: Moneycontrol.com
Shares of Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company (SPARC) rallied 9-10 percent intraday on Wednesday to hit record highs of Rs 1,035 and Rs 448.80, respectively. SPARC, the subsidiary of pharma major, has received approval from US Food and Drug Administration (USFDA) for antiepileptic drug.
Mar 02, 2015 at 20:15 | Source: PTI
As on December 31, 2014, the company had a total of 781 filings for formulations of which 333 have been approved in various regions globally.
Mar 02, 2015 at 16:11 | Source: Moneycontrol.com
Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Montelukast Sodium Chewable Tablets, 4 mg and 5 mg, the generic version of Singulair Chewable Tablets (of Merck), which is used for the treatment of asthma and to relieve symptoms of seasonal allergies.
Feb 25, 2015 at 11:43 | Source: Moneycontrol.com
Investors bought more shares of Jubilant Life Sciences on Wednesday on getting approval from the USFDA for its allergies and hypertension drugs. The stock rallied 6 percent intraday today on top of 4 percent upside seen in previous session.
Feb 23, 2015 at 15:17 | Source: Reuters
The FDA inspected the plant in January this year, after which it issued the company a so-called Form 483, listing six observations on the manufacturing processes at the plant, Lupin said in a statement, without giving details.
Feb 11, 2015 at 11:51 | Source: CNBC-TV18
For investing, one should look at getting into fundamentally sound stocks and sectors that have consistently performed but the wait could be longer, says Nipun Mehta of Blue Ocean Capital Advisors.
Jan 23, 2015 at 15:12 | Source: Moneycontrol.com
Investors offloaded a huge chunk of shares of Ipca Laboratories on Friday. The stock fell nearly 9 percent intraday. The pharmaceutical firm received import alert from US Food and Drug Administration for its Ratlam unit due to violations of standard production practices.
Jan 07, 2015 at 09:59 | Source: Moneycontrol.com
"Aurobindo received final approval from the US Food & Drug Administration to manufacture and market Valsartan tablets USP, 40mg, 80mg, 160mg and 320mg. The product is ready for launch," said the pharmaceutical company in its filing to the exchange.
Jan 06, 2015 at 18:47 | Source: PTI
The companies have received final approval from the US Food and Drug Administration (USFDA) for their abbreviated new drug applications for Valsartan tablets USP in multiple strengths of 40 mg, 80 mg, 160 mg and 320 mg, domestic firms said in separate statements.
Jan 06, 2015 at 11:09 | Source: Moneycontrol.com
"Jubilant received abbreviated new drug application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Mycophenolate Mofetil USP and Rizatriptan," said the pharmaceuticals and life sciences company in its filing to the exchange.
Messages on Us Food And Drug Administration »

ahaslaltirm
a

Platinum Member

369 Followers

Wockhardt  

Jun 05, 2014, 04.15 PM IST | Source: PTI Wockhardt recalls 8712 hypertension drug bottles in US mkt According to US Food and Drug Administration (USFDA), Wockhardt USA Inc, a subsidiary of Mumbai-based firm is voluntarily recalling 8,712 bottles of the drug in the American market.

10.30 AM Jul 7th 2014

Neha-Diwan

Platinum Member

805 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG`s blood pressure pill Diovan. Ranbaxy will be the first rival drug maker to launch a copy of Diovan in the United States and will be entitled to six months

10.20 AM Jun 30th 2014

Amrita Gaba

New Member

401 Followers

Strides Arcolab  

Strides Arcolab has received regulatory approval to market a skin disease drug in the US. The US Food and Drug Administration (FDA) has allowed the company to sell Methoxsalen capsules of 10 mg strength, Bangalore-based Strides Arcolab said in a statement. The US market for generic Methoxsalen

12.33 PM Jun 9th 2014

Willwin

Platinum Member

332 Followers

Wockhardt  

he U.S. Food and Drug Administration has expressed concerns over production processes at the U.S. unit of Wockhardt and there is a real possibility that its USA unit is banned by USFDA. If that happens the share will sink below 400. For the time being IMO,it will go down to 450-500 range.

10.16 AM May 29th 2014

Willwin

Platinum Member

332 Followers

Wockhardt  

1.01 PM May 28th 2014

Web Messenger

Platinum Member

273640 Followers

Wockhardt  

Source:NDTV Profit - Mumbai: The US Food and Drug Administration (FDA) has made some observations about the production process of the US unit of Indian generic drugmaker Wockhardt Ltd, the company said on Tuesday. The FDA last year banned Wockhardt's two Indian ...

7.12 PM May 27th 2014

shakira9

New Member

3 Followers

Sun Pharma  

to increased scrutiny from regulators concerned that the quality of drugs made in that country aren’t up to US standards. The concerns prompted Margaret Hamburg, the commissioner of the US Food and Drug Administration (FDA), to go to India in February to meet with pharmaceutical makers there about production

12.14 PM May 15th 2014

Web Messenger

Platinum Member

273640 Followers

News Now  

Source:Money Rediff News Report - New Delhi: India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday. As part of

2.34 PM May 7th 2014

Web Messenger

Platinum Member

273640 Followers

News Now  

Source:Calcutta Telegraph News - New Delhi, May 6: Problems faced by Indian drug makers in the US are not related to quality but to documentation and data maintenance, a senior government official said today. Stressing that India is already engaged with the US Food and Drug Administration (USFDA

1.48 PM May 7th 2014

arvinddhaka
d1987

New Member

0 Follower

Just Posted  

of Fall in the gearing level, Higher earnings growth, Removal of US Food and Drug Administration. We would like to assigned Buy rating to APL with a target price of Rs700 in one to two months.

6.33 PM Apr 23rd 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.